about
Pathogenic Chlamydia Lack a Classical Sacculus but Synthesize a Narrow, Mid-cell Peptidoglycan Ring, Regulated by MreB, for Cell Division.Outer membrane biogenesis in Escherichia coli, Neisseria meningitidis, and Helicobacter pylori: paradigm deviations in H. pyloriGenotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.The antibiotic potential of prokaryotic IMP dehydrogenase inhibitorsHelicobacter pylori salvages purines from extracellular host cell DNA utilizing the outer membrane-associated nuclease NucT.Construction of mobilizable mini-Tn7 vectors for bioluminescent detection of gram-negative bacteria and single-copy promoter lux reporter analysis.Helicobacter pylori relies primarily on the purine salvage pathway for purine nucleotide biosynthesisStructural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis.A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis.Genomic Comparison of cag pathogenicity island (PAI)-positive and -negative Helicobacter pylori strains: identification of novel markers for cag PAI-positive strainsChlamydia trachomatis dapF Encodes a Bifunctional Enzyme Capable of Both d-Glutamate Racemase and Diaminopimelate Epimerase Activities.Chlamydial MreB Directs Cell Division and Peptidoglycan Synthesis in Escherichia coli in the Absence of FtsZ ActivityChlamydia trachomatis Oligopeptide Transporter Performs Dual Functions of Oligopeptide Transport and Peptidoglycan RecyclingFosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly
P50
Q27314570-01332ECD-BBC0-4BA8-982A-EBF8DE877AC6Q30155248-D51AC076-21FA-4D47-8E8A-B97C4C66F3ECQ30278439-1D234051-70D2-42CA-9A43-712AC15CB9DBQ30356398-DD3BBF81-C626-4343-AC43-B9BB16742F66Q30414054-D834E8D5-D19E-4310-AF24-995B66F63928Q30415438-7E901D00-F19C-45D0-8D7A-C3E43F1E1102Q30425739-7E430532-5A74-4115-A75D-1FC8C9823BA0Q30430133-4A411FBF-E054-4FBC-9383-5E96CEF13555Q30436545-F981E1FE-2397-4DB7-A420-D49225ECD53AQ30576851-A2EF1C68-B933-441D-9D1F-48FDCBD1C1CFQ33788092-6A772254-3EF0-4AC9-9435-06AADC5B8073Q52609087-6BB7A3D7-C689-492F-852B-9DE5781D4A73Q89766939-B1FD4DDF-D164-4352-9BE5-BD809D3187A7Q89865430-7B954231-3B18-4943-9392-969EC368C526Q90770799-59456E45-3196-4D2F-8C9D-5242ECB488EC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
George W Liechti
@ast
George W Liechti
@en
George W Liechti
@es
George W Liechti
@nl
type
label
George W Liechti
@ast
George W Liechti
@en
George W Liechti
@es
George W Liechti
@nl
prefLabel
George W Liechti
@ast
George W Liechti
@en
George W Liechti
@es
George W Liechti
@nl
P106
P21
P31
P496
0000-0003-3028-8474